当前位置:首页 - 行情中心 - 国药现代(600420) - 财务分析 - 现金流量表

国药现代

(600420)

  

流通市值:106.57亿  总市值:119.50亿
流通股本:11.96亿   总股本:13.41亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金8,024,058,613.725,321,280,999.622,458,359,184.912,385,563,548.45
收到的税费返还58,806,063.6449,454,380.141,190,012.96268,080,326.12
收到其他与经营活动有关的现金484,677,295.88421,355,423.35167,321,463.43838,567,973.27
经营活动现金流入的平衡项目0000
经营活动现金流入小计8,567,541,973.245,792,090,803.072,666,870,661.2913,492,211,847.84
购买商品、接受劳务支付的现金3,223,189,185.582,113,439,025.43948,988,827.054,862,918,872.27
支付给职工以及为职工支付的现金1,227,638,626.86846,939,564.69481,541,704.051,516,495,143.84
支付的各项税费650,815,042.31490,502,997.78249,327,236.77885,730,723.4
支付其他与经营活动有关的现金2,019,356,171.831,429,506,565.38717,452,585.513,371,434,003.17
经营活动现金流出的平衡项目0000
经营活动现金流出小计7,120,999,026.584,880,388,153.282,397,310,353.3810,636,578,742.68
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额1,446,542,946.66911,702,649.79269,560,307.912,855,633,105.16
二、投资活动产生的现金流量:
收回投资收到的现金1,356,023.891,356,023.891,356,023.89-
取得投资收益收到的现金26,051,263.78---
处置固定资产、无形资产和其他长期资产收回的现金净额1,328,920.8825,423.4229,623.45,003,137.98
投资活动现金流入的平衡项目0000
投资活动现金流入小计28,736,208.472,181,447.291,585,647.295,003,137.98
购建固定资产、无形资产和其他长期资产支付的现金248,694,123.69173,957,473.3131,448,715.74307,440,212.11
支付其他与投资活动有关的现金493,498,222.22---
投资活动现金流出的平衡项目0000
投资活动现金流出小计742,192,345.91173,957,473.3131,448,715.74307,440,212.11
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-713,456,137.44-171,776,026.01-129,863,068.45-302,437,074.13
三、筹资活动产生的现金流量:
吸收投资收到的现金---1,187,999,998.87
取得借款收到的现金45,000,00025,000,000-2,345,800,000
筹资活动现金流入平衡项目00-0
筹资活动现金流入小计45,000,00025,000,000-3,533,799,998.87
偿还债务支付的现金752,800,000727,800,000727,800,0003,186,240,501.36
分配股利、利润或偿付利息支付的现金338,500,067.57146,013,566.4864,391,863.42347,516,344.74
其中:子公司支付给少数股东的股利、利润87,032,635.486,661,489.155,107,617.57162,812,095.59
支付其他与筹资活动有关的现金14,520,580.4713,774,784.435,273,738.79435,360,381.96
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,105,820,648.04887,588,350.91797,465,602.213,969,117,228.06
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-1,060,820,648.04-862,588,350.91-797,465,602.21-435,317,229.19
四、汇率变动对现金及现金等价物的影响24,787,371.621,377,290.6-6,181,466.694,242,063.28
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-302,946,467.2-121,284,436.53-663,949,829.352,212,120,865.12
加:期初现金及现金等价物余额5,834,875,955.525,834,875,955.525,834,875,955.523,622,755,090.4
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额5,531,929,488.325,713,591,518.995,170,926,126.175,834,875,955.52
补充资料:
净利润-514,521,310.56-867,484,979.36
资产减值准备-44,862,145.75-29,114,041.52
固定资产和投资性房地产折旧-369,652,763.29-791,685,451.58
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-369,652,763.29-791,685,451.58
无形资产摊销-18,019,096.36-38,320,396.57
长期待摊费用摊销-2,994,356.22-6,055,644.4
处置固定资产、无形资产和其他长期资产的损失-608,300.68-1,103,438.73
固定资产报废损失-333,129.17-3,428,396.73
公允价值变动损失-3,852,000--
财务费用-37,752,851.78-107,310,329.82
投资损失-8,009,983.45--2,342,528.35
递延所得税-7,365,418.82--56,981,195.76
其中:递延所得税资产减少-8,836,832.92--50,339,294.53
递延所得税负债增加--1,471,414.1--6,641,901.23
存货的减少-108,399,594.14-625,237,971.7
经营性应收项目的减少-8,342,387.91-463,120,113.04
经营性应付项目的增加--220,211,756.5--30,386,582.66
现金的期末余额-5,713,591,518.99-5,834,875,955.52
减:现金的期初余额-5,834,875,955.52-3,622,755,090.4
公告日期2023-10-282023-08-292023-04-262023-03-30
审计意见(境内)标准无保留意见
TOP↑